Catalyst Wire Dossier Catalyst Wire Dossier

VIZAMYL

Flutemetamol F-18 · GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare)
Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for VIZAMYL, covering 2013-10-25 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol [Phase 2]

See pricing